(Q39103952)

9 September 2017

Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts (English)

1 reference

9 September 2017

Sarah K Maenhout

1

1 reference

9 September 2017

Sandra Van Lint

2

1 reference

9 September 2017

Perpetua U Emeagi

3

1 reference

9 September 2017

Kris Thielemans

4

1 reference

9 September 2017

Joeri L Aerts

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

23 September 2013

1 reference

International Journal of Cancer

9 September 2017

1 reference

9 September 2017

134

1 reference

9 September 2017

5

1 reference

9 September 2017

1077-1090

1 reference

Does the immune system see tumors as foreign or self?

9 September 2017

1 reference

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

On the armament and appearances of human myeloid-derived suppressor cells

21 January 2018

1 reference

T-regulatory cells: key players in tumor immune escape and angiogenesis

21 January 2018

1 reference

The terminology issue for myeloid-derived suppressor cells

21 January 2018

1 reference

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

Subsets, expansion and activation of myeloid-derived suppressor cells

21 January 2018

1 reference

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

21 January 2018

1 reference

Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling

21 January 2018

1 reference

The balance of immune responses: costimulation verse coinhibition

21 January 2018

1 reference

The complex role of B7 molecules in tumor immunology

21 January 2018

1 reference

Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family

21 January 2018

1 reference

The B7 family and cancer therapy: costimulation and coinhibition

21 January 2018

1 reference

CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells

21 January 2018

1 reference

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells

21 January 2018

1 reference

CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells

21 January 2018

1 reference

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

21 January 2018

1 reference

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells

21 January 2018

1 reference

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

21 January 2018

1 reference

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site

21 January 2018

1 reference

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

21 January 2018

1 reference

Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.

21 January 2018

1 reference

Myeloid derived suppressor cells in human diseases

21 January 2018

1 reference

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

21 January 2018

1 reference

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.

21 January 2018

1 reference

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells

21 January 2018

1 reference

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas

21 January 2018

1 reference

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28449

1 reference

9 September 2017

1 reference